News
Ascendiant Capital Initiates Coverage On Cyclo Therapeutics with Buy Rating, Announces Price Target of $2.6
22 Apr 24
News, Price Target, Initiation, Analyst Ratings
12 Health Care Stocks Moving In Thursday's After-Market Session
18 Apr 24
Movers
12 Health Care Stocks Moving In Tuesday's After-Market Session
2 Apr 24
Movers
Cyclo Therapeutics Receives Decision To Grant European Patent Titled 'METHODS FOR TREATING ALZHEIMER'S DISEASE WITH HP-[BETA]-CYCLODEXTRIN'
2 Apr 24
News, Legal
Cyclo Therapeutics Announces Issuance Of U.S. Patent Covering The Use Of Trappsol Cyclo For The Treatment Of Alzheimer's Disease
14 Mar 24
Biotech, News, General
12 Health Care Stocks Moving In Wednesday's After-Market Session
13 Mar 24
Movers